These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7202450)

  • 1. Cystinuria in children.
    Pavanello L; Rizzoni G; Dussini N; Zacchello G; Passerini G; Tasca A; Pagano F
    Eur Urol; 1981; 7(3):139-43. PubMed ID: 7202450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotic syndrome during treatment with alpha-mercaptopropionylglycine.
    Rizzoni G; Pavanello L; Dussini N; Chiandetti L; Zacchello G
    J Urol; 1979 Sep; 122(3):381-2. PubMed ID: 470014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cystinuria with alpha-mercaptopropionylglycine.
    Johansen K; Gammelgård PA; Jørgensen FS
    Scand J Urol Nephrol; 1980; 14(2):189-92. PubMed ID: 7209424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria.
    Harbar JA; Cusworth DC; Lawes LC; Wrong OM
    J Urol; 1986 Jul; 136(1):146-9. PubMed ID: 3712602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mercaptopropionylglycine: a progress in cystine stone therapy.
    Hautmann R; Terhorst B; Stuhlsatz HW; Lutzeyer W
    J Urol; 1977 May; 117(5):628-30. PubMed ID: 870714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine.
    Pak CY; Fuller C; Sakhaee K; Zerwekh JE; Adams BV
    J Urol; 1986 Nov; 136(5):1003-8. PubMed ID: 3534301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotic syndrome occurring during tiopronin treatment for cystinuria.
    Tasic V; Lozanovski VJ; Ristoska-Bojkovska N; Sahpazova E; Gucev Z
    Eur J Pediatr; 2011 Feb; 170(2):247-9. PubMed ID: 20924604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of nephrotic syndrome due to alpha-mercaptopropionyl glycine in a patient with familial cystinuria.
    Shibasaki T; Murai S; Kodama K; Nakano H; Ishimoto F; Sakai O
    Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):933-7. PubMed ID: 2250412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative treatment of cystine calculi: effect of oral alpha-mercaptopropionylglycine on cystine stone dissolution and on prevention of stone recurrence.
    Koide T; Kinoshita K; Takemoto M; Yachiku S; Sonoda T
    J Urol; 1982 Sep; 128(3):513-6. PubMed ID: 7120556
    [No Abstract]   [Full Text] [Related]  

  • 10. Pemphigus foliaceus and proteinuria induced by alpha-mercaptopropionylglycine.
    Lucky PA; Skovby F; Thier SO
    J Am Acad Dermatol; 1983 May; 8(5):667-72. PubMed ID: 6863624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cystine stone therapy with mercapto-propyonyl-glycine (MPG) (Thiola) (author's transl)].
    Terhorst B; Stuhlsatz HW
    Urologe A; 1975 Jul; 14(4):190-3. PubMed ID: 808002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of treatment of cystinuria and cystine lithiasis with alpha-mercaptopropionylglycine. Apropos of 40 patients].
    Giannakopoulos X; Kalfakakou V; Tsoumanis P; Karkabounas S; Giannakis D; Chambilomatis P; Evangelou A; Kallistratos G
    J Urol (Paris); 1994; 100(3):129-34. PubMed ID: 7836789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine cystinuria: an extended study on the effects of 2-mercaptopropionylglycine on cystine urolithiasis and urinary cystine excretion.
    Hoppe A; Denneberg T; Jeppsson JO; Kågedal B
    Br Vet J; 1993; 149(3):235-51. PubMed ID: 8334506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on cystinuria in children--the stone management and the prevention of calculi recurrence].
    Asanuma H; Nakai H; Takeda M; Shishido S; Kawamura T; Nagakura K; Yamafuji M
    Nihon Hinyokika Gakkai Zasshi; 1998 Sep; 89(9):758-65. PubMed ID: 9796255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical aspects of cystinuria and its treatment by thiola (author's transl)].
    Zechner O; Latal D; Gründig E; Müller M
    Wien Klin Wochenschr; 1976 Feb; 88(3):101-5. PubMed ID: 960706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperlipidemia associated with alpha-mercaptopropionylglycine therapy for cystinuria.
    Siskind MS; Popovtzer MM
    Am J Kidney Dis; 1992 Feb; 19(2):179-80. PubMed ID: 1739102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nephrotic syndrome and anasarca status, secondary to treatment with tiopronin in a case of cystinuria].
    Alvarez Navascués R; Vidau Argüelles P; Rodríguez Suarez C; Herrera Pérez de Villar J; Suarez Heiva M
    Arch Esp Urol; 2001 Jun; 54(5):438-40. PubMed ID: 11494716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course and cystine stone formation during tiopronin treatment.
    Lindell A; Denneberg T; Hellgren E; Jeppsson JO; Tiselius HG
    Urol Res; 1995; 23(2):111-7. PubMed ID: 7676533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Mercaptopropionate, a novel metabolite formed during treatment with 2-mercaptopropionyl-glycine in cystinuria.
    Mårtensson J; Denneberg T; Kågedal B
    Eur J Clin Pharmacol; 1986; 31(1):119-21. PubMed ID: 3780820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myopathy due to mercaptopropionyl glycine.
    Hales DS; Scott R; Lewi HJ
    Br Med J (Clin Res Ed); 1982 Oct; 285(6346):939. PubMed ID: 6811078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.